CoChat

197 POSTER Denosumab is a selective inhibitor of human receptor activator of NF-kB ligand that blocks osteoclast formation in vitro and in vivo

Elliott, R., Kostenuik, P., Chen, C., Kelley, M., Hawkins, N., Housman, J., McCabe, S., Mukku, V., Sullivan, J., Dougall, W. · 2006 · European Journal of Cancer Supplements

The DOI matches its Crossref record.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1359-6349(06)70202-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 15

Metadata

Authors
Elliott, R., Kostenuik, P., Chen, C., Kelley, M., Hawkins, N., Housman, J., McCabe, S., Mukku, V., Sullivan, J., & Dougall, W.
Venue
European Journal of Cancer Supplements
Publisher
Elsevier BV
Published
2006-11
Volume
4
Issue
12
Pages
62
ISSN
1359-6349 (ISSN-L)
OpenAlex
W2026115199
Cited by
14
References
0
Citations by year
2023: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2012: 2
Type
conference abstract
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
European Journal of Cancer Supplements (publishedVersion)
Topics
  • Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords
denosumab, RANKL inhibition, osteoclastogenesis, bone resorption, head and neck cancer, human papillomavirus, p16, tonsillar carcinoma, base of tongue cancer, smoking, prognosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 197 POSTER Denosumab is a selective inhibitor of human receptor activator of NF-kB ligand that blocks osteoclast formation in vitro and in vivo. https://app.cochat.ai/papers/10.1016/s1359-6349(06)70202-6
The paper
Elliott, R., Kostenuik, P., Chen, C., Kelley, M., Hawkins, N., Housman, J., McCabe, S., Mukku, V., Sullivan, J., & Dougall, W. (2006). 197 POSTER Denosumab is a selective inhibitor of human receptor activator of NF-kB ligand that blocks osteoclast formation in vitro and in vivo. European Journal of Cancer Supplements. https://doi.org/10.1016/s1359-6349(06)70202-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.